Literature DB >> 21073435

Synthesis and in vitro evaluation of some isatin-thiazolidinone hybrid analogues as anti-proliferative agents.

P K Ramshid1, Sankar Jagadeeshan, Anand Krishnan, Mary Mathew, S Asha Nair, M Radhakrishna Pillai.   

Abstract

A range of isatin-thiazolidinone hybrid analogues were synthesized and their cytotoxicity was evaluated against several cancer cell lines in vitro. The acute toxicity studies in mice models revealed that these analogues possess low systemic toxicity and are safe up to 1600mg/Kg. Among the compounds synthesized, 5-(2-nitrobenzylidene)-2-(isatin-3-azino)-thiazolidin-4-one (CI) has been shown to be the most active, highly promising compound which induced S phase arrest in cell cycle in a time dependent manner. Our initial analysis indicate that incorporation of electron withdrawing group at ortho position of the ring favors over the meta and para positions for eliciting its cytostatic effect. Overall, the in vitro biological evaluation suggests that the growth inhibitory effect of CI is promising and can be studied further.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073435     DOI: 10.2174/157340610793358909

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  4 in total

1.  A facile synthesis and anticancer activity evaluation of spiro[thiazolidinone-isatin] conjugates.

Authors:  Danylo Kaminskyy; Dmytro Khyluk; Olexandr Vasylenko; Lucjusz Zaprutko; Roman Lesyk
Journal:  Sci Pharm       Date:  2011-10-03

2.  Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling.

Authors:  Hatem A Abdel-Aziz; Wagdy M Eldehna; Adam B Keeton; Gary A Piazza; Adnan A Kadi; Mohamed W Attwa; Ali S Abdelhameed; Mohamed I Attia
Journal:  Drug Des Devel Ther       Date:  2017-08-09       Impact factor: 4.162

3.  Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents.

Authors:  Wagdy M Eldehna; Hadia Almahli; Ghada H Al-Ansary; Hazem A Ghabbour; Mohamed H Aly; Omnia E Ismael; Abdullah Al-Dhfyan; Hatem A Abdel-Aziz
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

4.  Novel Thiazolidinone/Thiazolo[3,2-a]Benzimidazolone-Isatin Conjugates as Apoptotic Anti-proliferative Agents Towards Breast Cancer: One-Pot Synthesis and In Vitro Biological Evaluation.

Authors:  Mohamed El-Naggar; Wagdy M Eldehna; Hadia Almahli; Amr Elgez; Mohamed Fares; Mahmoud M Elaasser; Hatem A Abdel-Aziz
Journal:  Molecules       Date:  2018-06-12       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.